Kindmark, Henrik, et al. “Five Patients With Malignant Endocrine Tumors Treated With Imatinib Mesylate (Glivec®)”. Acta Oncologica, vol. 49, no. 1, Jan. 2010, pp. 100-1, doi:10.3109/02841860902897707.